Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q4 2018 · 10-K
Revenue$141.08M$141.08M+16.3% vs Q4 2017 Net Income$6.11M$6.11M+149.1% vs Q4 2017 EPS Diluted$0.24$0.24+166.7% vs Q4 2017 Gross Profit$24,809,000+29.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived-$10,307,000N/M Free Cash Flowderived-$13,376,000N/M Margins · derivedGross margin17.6%+1.8 pt vs Q4 2017
Operating margin5.7%+4.4 pt vs Q4 2017
Net margin4.3%+2.3 pt vs Q4 2017
ended May 27, 2018 · filed Aug 9, 2018 · 74 d after period end